Evidence for reversible sequestration of morphine in rat liver

Biochemical Pharmacology

Volumn 52, Issue 4, 1996, Pages 535-541

  Matheny, Christopher J ^a   Taft, David R ^a   Brouwer, Kim L R ^a   Pollack, Gary M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

extravascular binding; hepatic uptake; isolated perfused liver; morphine; morphine 3 ,D glucuronide; subcellular distribution

Indexed keywords

MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

EID: 0029902244     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00304-8     Document Type: Article

References (24)

1. Ekblom M, Hammarlund-Udenaes M and Paalzow L, Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. J Pharmacol Exp Ther 266: 244-252, 1993.
2. Betschart HR, Jondorf WR and Bickel MH, Differences in adipose tissue distribution of basic drugs between intraperitoneal and other routes of administration. Xenobiotica 18: 113-121, 1988.
3. Joreteg T and Jogestrand T, Physical exercise and digoxin binding to skeletal muscle: Relation to exercise intensity. Eur J Clin Pharmacol 25: 585-588, 1983.
4. Pollack GM and Brouwer KLR, Physiologic and metabolic influences on enterohepatic recirculation: Simulations based upon the disposition of valproic acid in the rat. J Pharmacokinet Biopharm 19: 189-225, 1991.
5. Horton TL and Pollack GM, Enterohepatic recirculation and renal metabolism of morphine in the rat. J Pharm Sci 80: 1147-1152, 1991.
6. Walsh CT and Levine RR, Studies of the enterohepatic circulation of morphine in the rat. J Pharmacol Exp Ther 195: 303-310, 1975.
7. Kuo CK, Hanioka N, Hoshikawa Y, Oguri K and Yoshimura H, Species differences of site-selective glucuronidation of morphine. J Pharmacobiodyn 14: 187-193, 1991.
8. Sato H, Sugiyama Y, Sawada Y, Iga T and Hanano M, In vivo evidence for the specific binding of human β-endorphin to the lung and liver of the rat. Biochem Pharmacol 37: 2273-2278, 1988.
9. Khajawa XZ, Green IC, Thorpe JR and Titheradge MA, The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Biochem J 267: 233-240, 1990.
10. Martin IL, The benzodiazepine receptor. In Neuromethods 4. Receptor Binding (Eds. Boulton AA, Baker GB and Hrdina PD), pp. 415-453. Humana Press, Clifton, NJ, 1986.
11. Studenberg SD and Brouwer KLR, Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment. J Pharmacol Exp Ther 261: 1022-1027, 1992.
12. Brouwer KLR, Hall ES and Pollack GM, Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats. Biochem Pharmacol 45: 735-742, 1993.
13. Bulmer MG, Principles of Statistics, pp. 221-227. Dover, New York, 1979.
14. Gibaldi M and Perrier D, Apparent volume of distribution. Pharmacokinetics, 2nd Ed, pp. 199-219. Marcel Dekker, New York, 1982.
15. Sewell RB, Brook CW, Mihaly GW, Morgan DJ and Smallwood RA, Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole. Biochem Pharmacol 48: 846-849, 1994.
16. Iwamoto K, Eason DL and Klaassen CD, Uptake of morphine and nalorphine by isolated rat hepatocytes. J Pharmacol Exp Ther 206: 181-189, 1978.
17. Stegmann R and Bickel MH, Dominant role for tissue binding in the first-pass extraction of imipramine by the perfused rat liver. Xenobiotica 7: 737-746, 1977.
18. Matthew D, Brennan B, Zomorodi K and Houston JB, Disposition of azole antifungal agents. I. Nonlinearities in ketoconazole clearance and binding in rat liver. Pharm Res 10: 418-422, 1993.
19. Ervine CM and Houston JB, Disposition of azole antifungal agents. III. Binding of fluconazole and other azoles in rat liver. Pharm Res 11: 961-965, 1994.
20. Cox JW, Dring G, Ginsberg LC, Larson PG, Constable DA and Ulrich RG, Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes. Drug Metab Dispos 18: 726-731, 1990.
21. Allan EH, Green IC and Titheradge MA, The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides. Biochem J 216: 507-510, 1983.
22. Leach RP, Allan EH and Titheradge MA, The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides. Biochem J 227: 191-197, 1985.
23. Leach RP and Titheradge MA, The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides. Biochem J 238: 531-535, 1986.
24. Gabrielsson JL and Paalzow LK, A physiological pharmacokinetic model for morphine disposition in the pregnant rat. J Pharmacokinet Biopharm 11: 147-163, 1983.